MAPT and early-onset autosomal dominant Alzheimer disease: In Alzheimer’s disease (AD), the accumulation of cerebral amyloid-beta (Aβ) plaque pathology is assumed to initiate a cascade of pathological processes, including the expansion of hyperphosphorylated tau pathology from the temporal lobe to the cortex, thereby driving neurodegeneration and cognitive decline1,2.